Aerobic training programs and glycemic control in diabetic children in relation to exercise frequency

R Aouadi1, R Khalifa, A Aouidet

  • 1Research Unit, Evaluation and analysis of factors influencing sport performance, Tunis, Tunisia. ridha_aouadi@yahoo.fr

Insights

Regular aerobic exercise significantly improves glycemic control and lipid profiles in children with type 1 diabetes mellitus (T1DM). Exercising more than twice weekly for six months led to better HbA1c and cholesterol levels.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Exercise Physiology

Background:

  • Type 1 diabetes mellitus (T1DM) management requires careful attention to glycemic control and cardiovascular risk factors.
  • Aerobic training is a potential non-pharmacological intervention for improving metabolic health in pediatric populations.

Purpose of the Study:

  • To evaluate the impact of a six-month aerobic training program on glycemic control (HbA1c) and lipid profiles in children with T1DM.
  • To compare the effects of different exercise frequencies (twice weekly vs. four times weekly) on metabolic markers.

Main Methods:

  • Thirty-three children with T1DM were divided into three groups: control, aerobic training twice weekly (G1), and aerobic training four times weekly (G2).
  • Intervention lasted six months, with HbA1c and lipid profiles (HDL-C, LDL-C, TG) measured at baseline, three months, and six months.

Main Results:

  • After three months, G1 showed increased HDL-C, while G2 exhibited increased HDL-C and decreased TG.
  • After six months, G2 demonstrated significant improvements: increased HDL-C, decreased LDL-C and TG, and notably lower HbA1c compared to baseline.
  • G1 also showed significant improvements in HDL-C and TG after six months, but less pronounced metabolic benefits than G2.

Conclusions:

  • Aerobic training for six months, particularly when performed four times weekly, significantly improves glycemic control and lipid profiles in children with T1DM.
  • Encouraging regular, long-term physical activity is crucial for managing T1DM in pediatric patients.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...